Suppr超能文献

[灯盏花素通过介导富含半胱氨酸的蛋白61-结缔组织生长因子-肾母细胞瘤过度表达基因1的表达来减轻脂多糖诱导的肾损伤,从而抑制核因子-κB信号通路]

[Scutellarin alleviates lipopolysaccharide-induced renal injury via mediating cysteine-rich protein 61-connective tissue growth factor-nephroblastoma overexpressed gene 1 expression to inhibit nuclear factor-κB signaling pathway].

作者信息

Liu Xue, Qin Zhenzhi, Guan Chen, Xu Lingyu, Dai Jie, Yang Chengyu, Zhou Bin, Luan Hong, Zhao Long, Zhang Wei, Luo Congjuan, Xu Yan

机构信息

Department of Nephrology, the Affiliated Hospital of Qingdao University, Qingdao 266003, Shandong, China.

Qingdao University, Qingdao 266003, Shandong, China. Liu Xue is working on the Department of Nephrology, Linyi Central Hospital, Linyi 276400, Shandong, China. Corresponding author: Xu Yan, Email:

出版信息

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Apr;34(4):400-406. doi: 10.3760/cma.j.cn121430-20210401-00767.

Abstract

OBJECTIVE

To explore the protective effect and mechanism of scutellarin (Scu) on sepsis associated-acute kidney injury (SA-AKI).

METHODS

(1) In vivo experiment: 36 male C57BL/6 mice were divided into normal saline (NS) control group, lipopolysaccharide (LPS) induced SA-AKI model group (LPS group), 20 mg/kg Scu control group (Scu 20 control group), and 5, 10, 20 mg/kg Scu pretreatment groups by random number table with 6 mice in each group. The SA-AKI model was reproduced by intraperitoneal injection of 10 mg/kg LPS. The NS control group was injected with NS intraperitoneally. The Scu pretreatment groups were intraperitoneally injected with different doses of Scu every day before LPS injection for 1 week. Scu 20 control group was injected with 20 mg/kg Scu for 1 week. After 24 hours of LPS treatment, mice in each group were sacrificed, kidney tissues were collected, and kidney injury was detected by hematoxylin-eosin (HE) staining. Western blotting was used to detect the protein expression levels of nuclear factor-κB (NF-κB) signaling pathway related molecules, apoptosis-related proteins and cysteine-rich protein 61-connective tissue growth factor-nephroblastoma overexpressed gene 1 (CCN1). (2) In vitro experiment: human renal tubular epithelial cell line HK-2 was cultured in vitro and used for experiment when the cells fused to 80%. In the cells without LPS treatment and after 100 g/L LPS treatment, pcDNA3.1-CCN1 and small interfering RNA (siRNA) CCN1 sequence were transfected to overexpress and inhibit CCN1 expression, respectively, to observe whether CCN1 was involved in NF-κB signaling pathway activation and apoptosis. In addition, 100g/L LPS and 20 μmol/L Scu were added into HK-2 cells transfected with and without CCN1 siRNA to investigate the mechanism of protective effect of Scu on LPS-induced HK-2 cells injury.

RESULTS

(1) The results of in vivo experiment: the renal function of SA-AKI mice induced by LPS was significantly decreased, and had kidney histological damage and severely damaged renal tubules. Scu could alleviate renal function and histological damage in a dose-dependent manner. Western blotting results showed Scu could reduce the protein expression of NF-κB signaling pathway related molecules and CCN1 in the renal tissue, and had a significant alleviating effect on apoptosis, indicating that CCN1 was involved in NF-κB signaling pathway activation and apoptosis. (2) The results of in vitro experiment: in HK-2 cells not treated with LPS, CCN1 overexpression had no effect on apoptosis related protein and pro-inflammatory factors of NF-κB signaling pathway. In HK-2 cells treated with LPS, overexpression of CCN1 significantly inhibited the mRNA expressions of interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) and monocyte chemoattractant protein-1 (MCP-1), with significant differences as compared with cells stimulated only by LPS [IL-1β mRNA (2): 3.20±0.57 vs. 4.88±0.69, TNF-α mRNA (2): 2.99±0.44 vs. 5.00±0.81, MCP-1 mRNA (2): 2.81±0.50 vs. 5.41±0.75, all P < 0.05], and the apoptosis-related protein was significantly down-regulated. However, when siRNA was used to inhibit the expression of CCN1, the mRNA expressions of pro-inflammatory factors were significantly increased as compared with cells stimulated only by LPS [IL-1β mRNA (2): 6.01±1.13 vs. 4.88±0.69, TNF-α mRNA (2): 5.15±0.86 vs. 5.00±0.81, all P < 0.05], and apoptosis-related protein was significantly up-regulated. In the LPS-induced HK-2 cells, the mRNA expressions of pro-inflammatory factors were significantly down-regulated after Scu treatment as compared with cells stimulated only by LPS [IL-1β mRNA(2): 2.55±0.50 vs. 6.15±1.04, TNF-α mRNA (2): 2.58±0.40 vs. 3.95±0.52, MCP-1 mRNA (2): 2.64±0.44 vs. 6.21±0.96, all P < 0.05], and apoptosis-related protein was also significantly reduced. When the expression of CCN1 was inhibited by siRNA, the protective effect of Scu on cells was weakened, which showed that the mRNA expressions of pro-inflammatory factors in cells was significantly up-regulated compared with the cells without inhibition of CCN1 expression [IL-1β mRNA (2): 5.34±0.76 vs. 2.55±0.50, TNF-α mRNA (2): 3.66±0.54 vs. 2.58±0.40, MCP-1 mRNA (2): 5.15±0.79 vs. 2.64±0.44, all P < 0.05], and the expression of apoptosis related protein was also significantly up-regulated.

CONCLUSIONS

Scu could protect the renal function in SA-AKI mice, and the protective effect is associated with NF-κB signaling pathway and CCN1. Thus, Scu could alleviate LPS-induced kidney injury by regulating the NF-κB signaling pathway.

摘要

目的

探讨灯盏花素(Scu)对脓毒症相关性急性肾损伤(SA-AKI)的保护作用及机制。

方法

(1)体内实验:将36只雄性C57BL/6小鼠按随机数字表法分为生理盐水(NS)对照组、脂多糖(LPS)诱导的SA-AKI模型组(LPS组)、20mg/kg Scu对照组(Scu 20对照组)以及5、10、20mg/kg Scu预处理组,每组6只。通过腹腔注射10mg/kg LPS复制SA-AKI模型。NS对照组腹腔注射NS。Scu预处理组在LPS注射前每天腹腔注射不同剂量Scu,共1周。Scu 20对照组注射20mg/kg Scu,共1周。LPS处理24小时后,处死每组小鼠,收集肾组织,采用苏木精-伊红(HE)染色检测肾损伤情况。采用蛋白质印迹法检测核因子-κB(NF-κB)信号通路相关分子、凋亡相关蛋白及富含半胱氨酸蛋白61-结缔组织生长因子-肾母细胞瘤过度表达基因1(CCN1)的蛋白表达水平。(2)体外实验:体外培养人肾小管上皮细胞系HK-2,待细胞融合至80%时用于实验。在未用LPS处理的细胞及100g/L LPS处理后的细胞中,分别转染pcDNA3.1-CCN1和小干扰RNA(siRNA)CCN1序列以过表达和抑制CCN1表达,观察CCN1是否参与NF-κB信号通路激活及凋亡。此外,在转染有和未转染CCN1 siRNA的HK-2细胞中加入100g/L LPS和20μmol/L Scu,研究Scu对LPS诱导的HK-2细胞损伤的保护作用机制。

结果

(1)体内实验结果:LPS诱导的SA-AKI小鼠肾功能显著下降,出现肾脏组织学损伤,肾小管严重受损。Scu能以剂量依赖方式减轻肾功能及组织学损伤。蛋白质印迹结果显示,Scu可降低肾组织中NF-κB信号通路相关分子及CCN1的蛋白表达,并对凋亡有显著缓解作用,表明CCN1参与NF-κB信号通路激活及凋亡。(2)体外实验结果:在未用LPS处理的HK-2细胞中,CCN1过表达对NF-κB信号通路的凋亡相关蛋白及促炎因子无影响。在LPS处理的HK-2细胞中,CCN1过表达显著抑制白细胞介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)和单核细胞趋化蛋白-1(MCP-1)的mRNA表达,与仅用LPS刺激的细胞相比有显著差异[IL-1β mRNA(2):3.20±0.57 vs. 4.88±0.69,TNF-α mRNA(2):2.99±0.44 vs. 5.00±0.81,MCP-1 mRNA(2):2.81±0.50 vs. 5.41±0.75,均P<0.05],且凋亡相关蛋白显著下调。然而,当用siRNA抑制CCN1表达时,与仅用LPS刺激的细胞相比,促炎因子的mRNA表达显著增加[IL-1β mRNA(2):6.01±1.13 vs. 4.88±0.69,TNF-α mRNA(2):5.15±0.86 vs. 5.00±0.81,均P<0.05],凋亡相关蛋白显著上调。在LPS诱导的HK-2细胞中,Scu处理后促炎因子的mRNA表达与仅用LPS刺激的细胞相比显著下调[IL-1β mRNA(2):2.55±0.50 vs. 6.15±1.04,TNF-α mRNA(2):2.58±0.40 vs. 3.95±0.52,MCP-1 mRNA(2):2.64±0.44 vs. 6.21±0.96,均P<0.05],凋亡相关蛋白也显著减少。当用siRNA抑制CCN1表达时,Scu对细胞的保护作用减弱,表明与未抑制CCN1表达的细胞相比,细胞中促炎因子的mRNA表达显著上调[IL-1β mRNA(2):5.34±0.76 vs. 2.55±0.50,TNF-α mRNA(2):3.66±0.54 vs. 2.58±0.40,MCP-1 mRNA(2):5.15±0.79 vs. 2.64±0.44,均P<0.05],凋亡相关蛋白表达也显著上调。

结论

Scu可保护SA-AKI小鼠的肾功能,其保护作用与NF-κB信号通路及CCN1有关。因此,Scu可通过调节NF-κB信号通路减轻LPS诱导的肾损伤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验